In HIV, lymphoma survival tracks tumor stage and CD4 count, not viral suppression, a Spanish cohort shows.
|Articles|August 1, 2000
Supplements and Featured Publications
- A Rational Approach to Sexual Dysfunction for a Managed Care Population
- Volume 6
- Issue 12 Suppl
Introduction
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Current Concepts in Erectile Dysfunctionabout 26 years ago
Partner and Relationship Issues in the Treatment of Erectile Dysfunctionabout 26 years ago
A Clinical Perspective on Erectile Dysfunction Therapiesabout 26 years ago
Selected Abstractsabout 26 years ago
CME Quizabout 26 years ago
BibliographyAdvertisement
Related to this article
Polyphenols show lab promise for endometriosis, but human evidence is thin, and the best resveratrol pain trial was negative.
Those using e-cigarettes were more likely to develop cataracts, and those receiving cataract surgery less likely to develop depression and anxiety.
The conference session featured updates on several clinical trials, including the BRUNELLO trial, for treatment of diabetic macular edema (DME).
Experts explain why access to specialty cancer care, open dialogue, and patient education are essential to building trust and making informed treatment decisions.
An intraoperative indocyanine green (ICG) fluorescence imaging protocol in sarcoma surgery detected 14 of 15 positive margins vs 4 of 15 for surgeons, though its specificity was 41.7% vs 88.9%.
Panelists engaged in a debate regarding using complement inhibitors in geographic atrophy, gauging public sentiment with a deciding vote.
A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help patients receive peak care.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
2
A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD
3
Using Complement Inhibitors in GA Comes With Pros and Cons
4
Full POLARGO Data Reveal OS, Safety for Pola-R-GemOx in DLBCL
5